FDA Inspection
Landy InternationalLandy International – FDA Inspection, Dec 14, 2023
Record Details
This FDA Inspection record concerns Landy International, with an inspection on December 14, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 36201851-f788-4c6e-a2b2-0311391de491
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1227210
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
- Enforcement
- Warning Letter
FDA Citations
17- 21 CFR 211.68(b)Computer control of master formula records
- 21 CFR 211.68(b)Backup data not assured as exact and complete
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.160(b)(3)Drug products-sampling procedures/specifications
- 21 CFR 211.160(b)(1)Incoming lots - conformance to written specs-
- 21 CFR 211.165(e)Test methods
- 21 CFR 211.188(a)Accurate reproduction
- 21 CFR 211.166(a)Lack of written stability program
- 21 CFR 211.160(b)(4)Instruments, apparatus, et. al. not meeting specs
- 21 CFR 211.160(b)(1)Incoming lots - conformance to written specs-
Showing 10 of 17 citations.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Landy International
1| Date | Classification | Office | Project area |
|---|---|---|---|
| January 13, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Landy International
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.